Update
$Gain Therapeutics (GANX.US)$ Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease
2 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
2 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
annna : short attack
Trytosaveabit OP annna : True! Plus it’s phase 1 so not sure until market open what kinda interest is really there? GL
let it squeeze Trytosaveabit OP : I'm wondering if shorts went a little premature? grabbed the dip and will see what happens...I'm interested.
Trytosaveabit OP let it squeeze : I’m definitely watching